PON3

There are 4 papers on PON3 in aging research: 1 trial and 3 observational studies in people. The newest story, Oct 31, 2026: “Blood protein patterns linked to differing heart failure risk”.

Biomarker

4 papers study it1 finding

1 new paper in 30 daysSee all 4

  • Human trial1
  • Humans3

Upstream

1

Sarcopenia

downin humans1

1 study
  1. Sarcopenia is linked with lower PON3 in humans (sarcopenia vs controls).

    “Paraoxonase-3 (PON3) consistently showed down-regulation in the sarcopenic group across both methodologies.”

    Humanssarcopenia vs controlsplasma

    Plasma biomarkers in patients with age-related sarcopenia: a proteomic exploration and experimental validation

    Aging clinical and experimental research

More on Sarcopenia

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 1Nov 2026: 03 papers in 12 months
Frontiers in Endocrinology

Blood protein patterns linked to differing heart failure risk

A four-protein panel improved prediction beyond clinical factors and an existing blood marker, raising a measure of how well the model ranked risk by 0.021.A four-protein panel improved prediction beyond clinical factors and an existing blood marker, raising a measure of how well the model ranked risk by 0.021.

Accepted, not yet published: cohort · 42,324 peopleHeart failure